Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT ID: NCT01429389
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2011-05-31
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* provides signed and dated informed consent
* subject is at increased risk for fetal aneuploidy
* subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis
* subject agrees to provide the genetic results of the invasive procedure
Exclusion Criteria
* Previous sample donation under this protocol
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sequenom, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Grosu, MD
Role: STUDY_DIRECTOR
Sequenom, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama Birmingham
Birmingham, Alabama, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Sharp-Rees Stealy Medical Group
San Diego, California, United States
UCSD
San Diego, California, United States
Women's Health Care Research
San Diego, California, United States
Specialty Obstetrics of San Diego
San Diego, California, United States
Reproductive Genetics Institute
Chicago, Illinois, United States
University of Iowa Health Care
Iowa City, Iowa, United States
Henry Ford Hospital
Detroit, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
The Cooper Health System
Camden, New Jersey, United States
Medical University of South Carolina
Charleston, South Carolina, United States
IWK Health Centre
Halifax, Nova Scotia, Canada
North York General Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joseph Biggio, MD
Role: backup
Deebra Smith, MD
Role: primary
John Williams, MD
Role: backup
Mary LaPage
Role: primary
Denis Tarakjian, MD
Role: backup
Andrew Hull, MD
Role: backup
Rovena Reagan, MD
Role: backup
David Dowling, MD
Role: backup
Denise Ginsberg
Role: primary
Norman Ginsberg, MD
Role: backup
Kristi Borowski, MD
Role: backup
Jacquelyn Roberson, MD
Role: backup
Yvonne Edgerly
Role: primary
Asad Sheikh, MD
Role: backup
Meena Khandelwal, MD
Role: backup
Christopher Robinson, MD
Role: backup
Jo-Ann Brock, MD
Role: backup
Wendy Meschino, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SQNM-T21-107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.